Clark Estates Inc. NY Sells 65,000 Shares of Smith & Nephew plc (NYSE:SNN)

Clark Estates Inc. NY cut its stake in shares of Smith & Nephew plc (NYSE:SNN - Free Report) by 8.7% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 685,000 shares of the medical equipment provider's stock after selling 65,000 shares during the period. Smith & Nephew comprises approximately 4.0% of Clark Estates Inc. NY's holdings, making the stock its 5th largest position. Clark Estates Inc. NY owned approximately 0.16% of Smith & Nephew worth $21,331,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Mather Group LLC. boosted its stake in shares of Smith & Nephew by 9,735.3% during the 2nd quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider's stock valued at $42,000 after buying an additional 1,655 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in shares of Smith & Nephew by 1,894.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider's stock worth $43,000 after acquiring an additional 1,648 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in Smith & Nephew by 92.5% during the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider's stock valued at $61,000 after purchasing an additional 1,179 shares during the last quarter. GAMMA Investing LLC grew its stake in Smith & Nephew by 160.0% in the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider's stock valued at $70,000 after purchasing an additional 1,389 shares in the last quarter. Finally, Opal Wealth Advisors LLC acquired a new position in Smith & Nephew in the 2nd quarter worth about $101,000. Institutional investors and hedge funds own 25.64% of the company's stock.

Smith & Nephew Price Performance

NYSE:SNN traded up $0.41 during midday trading on Wednesday, reaching $25.71. The stock had a trading volume of 652,818 shares, compared to its average volume of 873,165. Smith & Nephew plc has a 1-year low of $23.65 and a 1-year high of $31.72. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The firm's fifty day simple moving average is $27.88 and its 200-day simple moving average is $27.90.

Analysts Set New Price Targets

SNN has been the subject of several analyst reports. StockNews.com lowered shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, November 12th. Berenberg Bank downgraded Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Wednesday, November 6th. Finally, Deutsche Bank Aktiengesellschaft downgraded Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Friday, November 1st. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Smith & Nephew has a consensus rating of "Hold".

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.